Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET, INDUSTRY INSIGHTS
6 REGULATORY FRAMEWORK
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF DIABETES WORLDWIDE
7.1.2 GROWING AWARENESS ABOUT THE IMPORTANCE OF GLYCEMIC CONTROL
7.1.3 GROWING DEMAND FOR POINT-OF-CARE TESTING DEVICES
7.2 RESTRAINTS
7.2.1 HIGH COST OF HBA1C TESTING DEVICES AND KITS
7.2.2 INADEQUATE HEALTHCARE INFRASTRUCTURE IN DEVELOPING COUNTRIES
7.3 OPPORTUNITIES
7.3.1 INCREASING ADOPTION OF HBA1C TESTING IN EMERGING MARKETS
7.3.2 INTEGRATION OF HBA1C TESTING WITH ELECTRONIC MEDICAL RECORDS AND TELEMEDICINE
7.4 CHALLENGES
7.4.1 INACCURATE RESULTS DUE TO INTERFERENCE FROM VARIOUS HEMOGLOBIN VARIANTS
7.4.2 CHALLENGES IN INTERPRETING HBA1C RESULTS IN PATIENTS WITH ANEMIA OR KIDNEY DISEASE
8 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 INSTRUMENTS
8.2.1 POINT OF CARE DEVICES
8.2.2 FACILITY BASED PLATFORM
8.3 REAGENTS AND CONSUMABLES
9 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET, BY MODE OF TESTING
9.1 OVERVIEW
9.2 PRESCRIPTION BASED TESTING
9.3 OTC TESTING
10 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 TURBIDIMETRIC INHIBITION IMMUNOASSAY
10.3 ION-EXCHANGE HPLC
10.4 AFFINITY BINDING CHROMATOGRAPHY
10.5 ENZYMATIC ASSAY
10.6 OTHERS
11 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 LABORATORIES
11.3 HOSPITALS
11.4 CLINICS
11.5 HOMECARE
11.6 AMBULATORY CENTRES
11.7 PHARMACIES/ DRUG STORES
11.8 OTHERS
12 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT SALES
12.3 THIRD PARTY DISTRIBUTION
12.4 RETAIL SALES
12.4.1 HOSPITAL PHARMACY
12.4.2 ONLINE PHARMACY
12.4.3 OTHERS
13 SAUDI ARABIA, TURKEY AND EGYPT HBA1C TESTING MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: SAUDI ARABIA
13.2 COMPANY SHARE ANALYSIS: TURKEY
13.3 COMPANY SHARE ANALYSIS: EGYPT
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 F.HOFFMANN- LA ROCHE LTD.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENTS
15.2 SIEMENS HEALTHINEERS AG
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
15.3 ORTHO CLINICAL DIAGNOSTICS
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 ARKRAY, INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 PRODUCT PORTFOLIO
15.4.3 RECENT DEVELOPMENTS
15.5 THERMO FISCHER SCIENTIFIC INC.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 ABBOTT
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIO RAD LABORATORIES, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 DIASYS DIAGNOSTIC SYSTEMS GMBH
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 DXGEN CORP.
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 A. MENARINNI DIAGNOSTICS S.R.L
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 PTS DIAGNOSTICS
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 RADIOMETER MEDICAL APS
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 TRINITY BIOTECH
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 VITROSENS BIOTECHNOLOGY
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 WONDFO
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Figure
FIGURE 1 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: SEGMENTATION
FIGURE 2 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: DATA TRIANGULATION
FIGURE 3 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: DROC ANALYSIS
FIGURE 4 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 SAUDI ARABIA, TURKEY, AND EGYPT HBA1C TESTING MARKET: SEGMENTATION
FIGURE 11 GROWING AWARENESS OF DIABETES AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE SAUDI ARABIA HBA1C TESTING MARKET FROM 2023 TO 2030
FIGURE 12 GROWING AWARENESS OF DIABETES AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE TURKEY HBA1C TESTING MARKET FROM 2023 TO 2030
FIGURE 13 GROWING AWARENESS OF DIABETES AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE EGYPT HBA1C TESTING MARKET FROM 2023 TO 2030
FIGURE 14 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SAUDI ARABIA HBA1C TESTING MARKET IN 2023 & 2030
FIGURE 15 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE TURKEY HBA1C TESTING MARKET IN 2023 & 2030
FIGURE 16 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EGYPT HBA1C TESTING MARKET IN 2023 & 2030
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF SAUDI ARABIA, TURKEY & EGYPT HBA1C TESTING MARKET
FIGURE 18 SAUDI ARABIA HBA1C TESTING MARKET: BY PRODUCT TYPE, 2022
FIGURE 19 SAUDI ARABIA HBA1C TESTING MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 20 SAUDI ARABIA HBA1C TESTING MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 21 SAUDI ARABIA HBA1C TESTING MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 TURKEY HBA1C TESTING MARKET: BY PRODUCT TYPE, 2022
FIGURE 23 TURKEY HBA1C TESTING MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 24 TURKEY HBA1C TESTING MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 25 TURKEY HBA1C TESTING MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 26 EGYPT HBA1C TESTING MARKET: BY PRODUCT TYPE, 2022
FIGURE 27 EGYPT HBA1C TESTING MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 28 EGYPT HBA1C TESTING MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 29 EGYPT HBA1C TESTING MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 30 SAUDI ARABIA HBA1C TESTING MARKET: BY MODE OF TESTING, 2022
FIGURE 31 SAUDI ARABIA HBA1C TESTING MARKET: BY MODE OF TESTING, 2023-2030 (USD MILLION)
FIGURE 32 SAUDI ARABIA HBA1C TESTING MARKET: BY MODE OF TESTING, CAGR (2023-2030)
FIGURE 33 SAUDI ARABIA HBA1C TESTING MARKET: BY MODE OF TESTING, LIFELINE CURVE
FIGURE 34 TURKEY HBA1C TESTING MARKET: BY MODE OF TESTING, 2022
FIGURE 35 TURKEY HBA1C TESTING MARKET: BY MODE OF TESTING, 2023-2030 (USD MILLION)
FIGURE 36 TURKEY HBA1C TESTING MARKET: BY MODE OF TESTING, CAGR (2023-2030)
FIGURE 37 TURKEY HBA1C TESTING MARKET: BY MODE OF TESTING, LIFELINE CURVE
FIGURE 38 EGYPT HBA1C TESTING MARKET: BY MODE OF TESTING, 2022
FIGURE 39 EGYPT HBA1C TESTING MARKET: BY MODE OF TESTING, 2023-2030 (USD MILLION)
FIGURE 40 EGYPT HBA1C TESTING MARKET: BY MODE OF TESTING, CAGR (2023-2030)
FIGURE 41 EGYPT HBA1C TESTING MARKET: BY MODE OF TESTING, LIFELINE CURVE
FIGURE 42 SAUDI ARABIA HBA1C TESTING MARKET: BY TECHNOLOGY, 2022
FIGURE 43 SAUDI ARABIA HBA1C TESTING MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 44 SAUDI ARABIA HBA1C TESTING MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 45 SAUDI ARABIA HBA1C TESTING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 46 TURKEY HBA1C TESTING MARKET: BY TECHNOLOGY, 2022
FIGURE 47 TURKEY HBA1C TESTING MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 48 TURKEY HBA1C TESTING MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 49 TURKEY HBA1C TESTING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 50 EGYPT HBA1C TESTING MARKET: BY TECHNOLOGY, 2022
FIGURE 51 EGYPT HBA1C TESTING MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 52 EGYPT HBA1C TESTING MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 53 EGYPT HBA1C TESTING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 54 SAUDI ARABIA HBA1C TESTING MARKET: BY END USER, 2022
FIGURE 55 SAUDI ARABIA HBA1C TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 56 SAUDI ARABIA HBA1C TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 57 SAUDI ARABIA HBA1C TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 58 TURKEY HBA1C TESTING MARKET: BY END USER, 2022
FIGURE 59 TURKEY HBA1C TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 60 TURKEY HBA1C TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 61 TURKEY HBA1C TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 62 EGYPT HBA1C TESTING MARKET: BY END USER, 2022
FIGURE 63 EGYPT HBA1C TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 64 EGYPT HBA1C TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 65 EGYPT HBA1C TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 66 SAUDI ARABIA HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 67 SAUDI ARABIA HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 68 SAUDI ARABIA HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 69 SAUDI ARABIA HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 70 TURKEY HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 71 TURKEY HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 72 TURKEY HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 73 TURKEY HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 74 EGYPT HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 75 EGYPT HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 76 EGYPT HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 77 EGYPT HBA1C TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 78 SAUDI ARABIA HBA1C TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 79 TURKEY HBA1C TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 80 EGYPT HBA1C TESTING MARKET: COMPANY SHARE 2022 (%)